Questcor Pharmaceuticals (QCOR) Misses Q3 Views
More News related to QCOR
- Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc.
- Morning Movers 10/03: BNI, DDRX, BDK, AIMC, RTEC, MEDW Higher; CKEC, TPGI, IBCP, NSTC, CMLS, HEB Lower
- Questcor Pharmaceuticals (QCOR) Misses Q3 Views
- Questcor Announces Third Quarter 2009 Results
- Child Neurology Foundation Announces $30,000 Grant for Research Into Cause and Treatment of Infantile Spasms
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) reports Q3 EPS of $0.02, 9 cents below the analyst estimate of $0.11. Revenue for the quarter was $13.9 million, which compares to the estimate of $22.89 million.
Sees full year gross margin 91-93%.
Related Categories
EarningsStocks Mentioned
+0.03Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
